2658-6533Research Results in Biomedicine2658-653310.18413/2313-8955-2019-5-1-0-41608PharmacologyComparative evaluation of the effectiveness of DMAE derivative 7-16, carbamilated darbepoetin and substance C7070 in correction of hypertensive neuroretinopathy in ratsComparative evaluation of the effectiveness of DMAE derivative 7-16, carbamilated darbepoetin and substance C7070 in correction of hypertensive neuroretinopathy in ratsLyubimovIgor I.LyubimovIgor I.GubarevaViktoriya O.GubarevaViktoriya O.VikaZ@rambler.ru20195100

Background: Increasing the effectiveness of drug therapy for hyperintensive neuroretinopathy is one of the important tasks of pharmacology and ophthalmology. The aim of the study: To assess the effectiveness of DMAE derivative 7-16, carbamylated darbepoetin and C7070 in comparative aspect in correction of hypertensive neuroretinopathy in rats. Materials and methods: The level of retinal microcirculation was assessed by laser Doppler flowmetry (LDF) using the Biopac-systems MP-150 software and hardware complex and the needle type sensor TSD-144 (USA), and the program AcqKnowledge 4.2. Dimethylaminoethanol derivative DMAE 7-16 (OJS company "All-Russian Scientific Center for safety of biologically active substances", Russia) was injected in doses of 12.5 mg/kg/day, 25 mg/kg/day intragastric. Substance C7070 (3-(1H-benzimidazole-2-yl)-1,2,2-trimethylcyclopentanone acid) (JSC "Experimental Plant "VLADMIVA", Russia) was injected intragastrically in a dose of 50 mg/kg. Carbamylated darbepoetin was injected subcutaneously in a dose of 300 mcg/kg. Picamilon (Pharmstandard-Ufavita, Russia) was chosen as a comparison drug injected from 22nd to 28th day of the experiment inclusively, intragastrically, in a dose of 30 mg/kg. The evaluation of the clinical course of hypertensive neuroretinopathy with the correction by investigated pharmacological agents was performed on day 29th of the experiment. Results: Effective retinal microcirculation correction was found in DMAE derivative 7-16 in a dose of 25 mg/kg and C7070 in a dose of 50 mg/kg, which exceeds the mean value in the group with picamilon correction and is comparable to the mean value in the control group. In groups with DMAE derivative 7-16 in a dose of 12.5 mg/kg and carbamylated darbepoetin in a dose of 300 µg/kg, the target values of the microcirculation level in retina were not achieved. According to the results of evaluation of the clinical course of hypertensive neuroretinopathy in the groups with the introduction of substance C7070, carbamylated darbepoetin and picamilon, the parameters of the eye fundus were returned to normal. With the introduction of DMAE derivative 7-16 in a dose of 12.5 mg/kg there was swelling and partial optic disc decoloration; in a dose of 25 mg/kg there was no edema. Conclusion: The most effective correction of hypertensive neuroretinopathy in Wistar rats was detected in DMAE derivative 7-16 in a dose of 25 mg/kg and C7070 in a dose of 50 mg/kg, superior to the picamilon.

Background: Increasing the effectiveness of drug therapy for hyperintensive neuroretinopathy is one of the important tasks of pharmacology and ophthalmology. The aim of the study: To assess the effectiveness of DMAE derivative 7-16, carbamylated darbepoetin and C7070 in comparative aspect in correction of hypertensive neuroretinopathy in rats. Materials and methods: The level of retinal microcirculation was assessed by laser Doppler flowmetry (LDF) using the Biopac-systems MP-150 software and hardware complex and the needle type sensor TSD-144 (USA), and the program AcqKnowledge 4.2. Dimethylaminoethanol derivative DMAE 7-16 (OJS company "All-Russian Scientific Center for safety of biologically active substances", Russia) was injected in doses of 12.5 mg/kg/day, 25 mg/kg/day intragastric. Substance C7070 (3-(1H-benzimidazole-2-yl)-1,2,2-trimethylcyclopentanone acid) (JSC "Experimental Plant "VLADMIVA", Russia) was injected intragastrically in a dose of 50 mg/kg. Carbamylated darbepoetin was injected subcutaneously in a dose of 300 mcg/kg. Picamilon (Pharmstandard-Ufavita, Russia) was chosen as a comparison drug injected from 22nd to 28th day of the experiment inclusively, intragastrically, in a dose of 30 mg/kg. The evaluation of the clinical course of hypertensive neuroretinopathy with the correction by investigated pharmacological agents was performed on day 29th of the experiment. Results: Effective retinal microcirculation correction was found in DMAE derivative 7-16 in a dose of 25 mg/kg and C7070 in a dose of 50 mg/kg, which exceeds the mean value in the group with picamilon correction and is comparable to the mean value in the control group. In groups with DMAE derivative 7-16 in a dose of 12.5 mg/kg and carbamylated darbepoetin in a dose of 300 µg/kg, the target values of the microcirculation level in retina were not achieved. According to the results of evaluation of the clinical course of hypertensive neuroretinopathy in the groups with the introduction of substance C7070, carbamylated darbepoetin and picamilon, the parameters of the eye fundus were returned to normal. With the introduction of DMAE derivative 7-16 in a dose of 12.5 mg/kg there was swelling and partial optic disc decoloration; in a dose of 25 mg/kg there was no edema. Conclusion: The most effective correction of hypertensive neuroretinopathy in Wistar rats was detected in DMAE derivative 7-16 in a dose of 25 mg/kg and C7070 in a dose of 50 mg/kg, superior to the picamilon.

C7070carbamylated darbepoetinDMAE derivative 7-16hypertensive neuroretinopathyC7070carbamylated darbepoetinDMAE derivative 7-16hypertensive neuroretinopathyСписок литературыDas B. Is the sarcolemmal or mitochondrial K (ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model? Life Sci. 2005;29;77(11):1226-1248. DOI: https://doi.org/10.1016/j.lfs.2004.12.042Shabelnikova AS, Peresypkina AA, Gubareva VO, et al. Pharmacological preconditioning by recombinant erythropoietin as the possibility of increasing the stability of tissue of the retina to reperfusion ischemia in experiment. Research result: pharmacology and clinical pharmacology. 2016;2(1(2)):25-29. DOI: 10.18413/2313-8971-2016-2-1-25-29Stepushina OA. [Combined use of retinal vessel calibrometry, adaptive optics and fluorescence angiography in early diagnostics and monitoring of diabetic angioretinopathy and hypertensive angiopathy]. Vestnik oftal'mologii. 2011;2:29. Russian.Konstantinidis L. Hypertension and the eye. Curr Opin Ophthalmol. 2016;27(6):514-521. DOI: 10.1097 / ICU.0000000000000307Shvetsova NE. [A study of the effects of the drug Selekarten on the retina: an experimental study] [dissertation]. Moscow; 2008. 157 p. Russian.Khurana AR, Khurana B, Chauhan S, et al. Hypertensive retinopathy an overview. Haryana J. Ophthalmol. 2014;7:64-66..Imshenetskaya T. [Diabetic retinopathy]. Medical Bulletin. [Internet]. 2009  May 7 [cited 2018 Sept 16]. Available from:   http://www.medvestnik.by/ru/sovremennii_podxod/view/diabeticheskaja-retinopatija-6710-2009/ Russian.Moshetova LK, Nesterov AP, Yegorov E.A.  Ophthalmology: 2006: guideline. Mezhregion. Assoc. ophthalmologists of Russia. Moscow: GEOTAR-Media; 2006. 242 p. Russian.Makarov PV. The method of treatment and prevention of eye diseases associated with eye tissue ischemia. Byulleten. 3:12. Russian.Berezhnova TA, et al. [Pharmacology: chemotherapeutic drugs]. Working book for students of the specialty "Medical and preventive care". Voronezh; 2016. Russian.Peresypkina AA, Gubareva VO, Levkova EA, et al. Correction of retinal angiopathy of hypertensive type by minoxidil, sildenafil in experiment. Research result: pharmacology and clinical pharmacology. 2016;2(4):34-44. DOI: 10.18413/2500-235X-2016-2-4-34-44.Peresypkina AA, Pokrovsky MV Shabelnikova AS, et al. [Electrophysiological and histomorphometric changes in the retina of rats under pharmacological preconditioning erythropoietin, nicorandil on the model of ischemia-reperfusion eyes]. Scientific statement BSU. Ser. Medicine. Pharmacy. 2014;11(182):113-117. Russian.Sarkisov KG. [Laser Doppler flowmetry as a method for assessing the state of blood flow in microvessels]. In: Methodology of flowmetry. Moscow; 1999:9-14. Russian.Girard MJ,  Dahlmann-Noor A,  Rayapureddi S, et al. Quantitative mapping of scleral fiber orientation in normal rat eyes. Invest. Ophthalmol. Vis. Sci. 2011;52(13):968-49693. DOI: 10.1167 / iovs.11-7894Cheng H, Nair G, Walker TA, et al. Structural and functional MRI reveals multiple retinal layers. Proc. Natl. Acad. Sci. USA. 2006;103(46):17525-17530. DOI: https://doi.org/10.1073/pnas.0605790103Аrustamova AA, Pokrovsky MV, Shabelnikova AS, et al. Analysis of the Russian wholesale market of eye drops for the period of 2006-1-3 sq. 2012. Russian medical and biological Bulletin. Akad. I.P. Pavlov. 2013;4:71-76. Russian.Cuspidi C, Macca G, Salerno M, et al. Evaluation of target organ damage in arterial hypertension: which role for qualitative funduscopic examination? Ital Heart J. 2001;2(9):702-706.Cuspidi C, Meani S, Valerio C, et al. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study. Blood Press. 2005;14(1):25-31. DOI: 10.1080/08037050510008805Kolman SA, van Sijl AM, van der Sluijs FA, et al. Consideration of hypertensive retinopathy as an important end-organ damage in patients with hypertension. J Hum Hypertens. 2017;31(2):121-125. DOI: 10.1038/jhh.2016.49Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med. 2004;351:2310-2317. DOI: 10.1056/NEJMra032865